Virginia Retirement Systems Et Al Incyte Corp Transaction History

Virginia Retirement Systems Et Al

$14.2 Billion
Q2 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Incyte Corp stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 735,325 shares of INCY stock, worth $56.9 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

735,325

Previous 862,025 14.7%

Holding current value

$56.9 Million

Previous $52.2 Million 4.06%

% of portfolio

0.35%

Previous 0.39%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$55.17 - $71.22 $6.99 Million - $9.02 Million	-126,700 Reduced 14.7%	735,325 $50.1 Million
Q1 2025 Jul 16, 2025	BUY	$60.0 - $75.26 $44.1 Million - $55.3 Million	735,200 Added 579.7%	862,025 $52.2 Million
Q3 2023 Jan 02, 2024	BUY	$57.77 - $65.93 $5.93 Million - $6.77 Million	102,700 Added 425.7%	126,825 $7.33 Million
Q2 2023 Aug 22, 2023	SELL	$60.95 - $75.51 $597,310 - $739,998	-9,800 Reduced 28.89%	24,125 $1.5 Million
Q1 2023 Jul 11, 2023	BUY	$70.23 - $86.01 $718,101 - $879,452	10,225 Added 43.14%	33,925 $2.45 Million
Q4 2022 May 17, 2023	SELL	$67.18 - $84.11 $665,082 - $832,689	-9,900 Reduced 29.46%	23,700 $1.9 Billion
Q3 2022 May 16, 2023	SELL	$66.18 - $82.86 $1.17 Million - $1.47 Million	-17,700 Reduced 34.5%	33,600 $2.24 Billion
Q1 2022 Apr 21, 2022	SELL	$66.02 - $79.71 $6.56 Million - $7.92 Million	-99,400 Reduced 65.96%	51,300 $4.07 Million
Q4 2021 Feb 03, 2022	SELL	$63.34 - $74.11 $8.73 Million - $10.2 Million	-137,900 Reduced 47.78%	150,700 $11.1 Million
Q3 2021 Oct 21, 2021	BUY	$68.67 - $84.02 $3.78 Million - $4.62 Million	55,000 Added 23.54%	288,600 $19.9 Million
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $1.2 Million - $1.31 Million	-15,000 Reduced 6.03%	233,600 $19.7 Million
Q1 2021 Apr 30, 2021	BUY	$76.02 - $100.5 $18.9 Million - $25 Million	248,600 New	248,600 $20.2 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $4.97 Million - $6.01 Million	-61,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $280,731 - $361,977	3,300 Added 5.67%	61,500 $5.52 Million
Q2 2020 Aug 12, 2020	SELL	$74.18 - $108.93 $9.28 Million - $13.6 Million	-125,100 Reduced 68.25%	58,200 $6.05 Million
Q1 2020 May 12, 2020	SELL	$63.18 - $85.97 $2.25 Million - $3.06 Million	-35,600 Reduced 16.26%	183,300 $13.4 Million
Q4 2019 Jan 27, 2020	SELL	$73.04 - $95.72 $36,520 - $47,860	-500 Reduced 0.23%	218,900 $19.1 Million
Q3 2019 Oct 22, 2019	BUY	$72.82 - $86.52 $6.01 Million - $7.15 Million	82,600 Added 60.38%	219,400 $16.3 Million
Q2 2019 Jul 26, 2019	BUY	$73.52 - $88.7 $5.6 Million - $6.76 Million	76,200 Added 125.74%	136,800 $11.6 Million
Q1 2019 Apr 25, 2019	SELL	$63.56 - $88.17 $953,400 - $1.32 Million	-15,000 Reduced 19.84%	60,600 $5.21 Million
Q4 2018 Feb 07, 2019	BUY	$58.5 - $69.94 $836,550 - $1 Million	14,300 Added 23.33%	75,600 $4.81 Million
Q3 2018 Nov 02, 2018	BUY	$61.75 - $74.23 $277,875 - $334,035	4,500 Added 7.92%	61,300 $4.24 Million
Q2 2018 Aug 03, 2018	BUY	$60.85 - $83.98 $3.46 Million - $4.77 Million	56,800 New	56,800 $3.81 Million

Others Institutions Holding INCY

# of Institutions

706

Shares Held

195M

Call Options Held

564K

Put Options Held

317K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Incyte Corp Transaction History